Status:
COMPLETED
A Trial to Reduce Hepatitis C Among Injection Drug Users - 1
Lead Sponsor:
Butler Hospital
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
HCV Negative Status
HCV Risk Behavior
Eligibility:
All Genders
18-75 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to examine the efficacy of a brief motivational intervention on the cumulative incidence of Hepatitis C.
Detailed Description
Injection drug users are at high risk for blood-borne viral infections during their first years of injecting when they are least likely to seek formal substance abuse treatment, and are likely to be p...
Eligibility Criteria
Inclusion
- current opiate or cocaine use
- HCV seronegative
- able to complete the study procedures in English
Exclusion
- current enrollment in a formal substance abuse treatment program
Key Trial Info
Start Date :
September 1 2000
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2006
Estimated Enrollment :
277 Patients enrolled
Trial Details
Trial ID
NCT00218192
Start Date
September 1 2000
End Date
November 1 2006
Last Update
May 22 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rhode Island Hospital
Providence, Rhode Island, United States, 02903